XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows From Operating Activities    
Net Income (Loss) $ 4,880 $ 5,152
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation, depletion and amortization 4,545 3,952
Impairments 34 1
Dry hole costs and leasehold impairments 48 102
Accretion on discounted liabilities 160 136
Deferred taxes 211 489
Distributions more (less) than income from equity affiliates 364 652
(Gain) loss on dispositions (88) (92)
Other 10 (7)
Working capital adjustments    
Decrease (increase) in accounts and notes receivable 148 2,246
Decrease (increase) in inventories (57) (23)
Decrease (increase) in prepaid expenses and other current assets (147) 295
Increase (decrease) in accounts payable (183) (1,614)
Increase (decrease) in taxes and other accruals (21) (2,032)
Net Cash Provided by Operating Activities 9,904 9,257
Cash Flows From Investing Activities    
Capital expenditures and investments (5,885) (5,820)
Working capital changes associated with investing activities 173 86
Acquisition of businesses, net of cash acquired 49 0
Proceeds from asset dispositions 178 426
Net sales (purchases) of investments (794) 1,549
Other (13) (5)
Net Cash Used in Investing Activities (6,292) (3,764)
Cash Flows From Financing Activities    
Issuance of debt 0 1,093
Repayment of debt (563) (1,200)
Issuance of company common stock (57) (95)
Repurchase of company common stock (2,346) (3,000)
Dividends paid (1,839) (2,838)
Other (63) (11)
Net Cash Used in Financing Activities (4,868) (6,051)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (69) (162)
Net Change in Cash, Cash Equivalents and Restricted Cash (1,325) (720)
Cash, cash equivalents and restricted cash at beginning of period [1] 5,899 6,694
Cash, Cash Equivalents and Restricted Cash at End of Period [1] $ 4,574 $ 5,974
[1]
Restricted cash of $280 million and $264 million is included in the "Other assets" line of our Consolidated Balance Sheet as of June 30, 2024 and December 31, 2023, respectively.